News

MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...
Online pharmacies are no longer allowed to run adverts for weight loss injections, the advertising watchdog has ruled.
A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...
A new scientific study into the weight loss drug Mounjaro has found that it may not lead to a worrying side effect as ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass. But scientists say one injection – ...